The MarketReader Minute
💊 BridgeBio Shares Dip Amid Debt Refinancing, Regeneron & Amgen See Positive Movement After Trial Results | Biotech Sector Insights
Among IBB's holdings, significant declines were noted for Vertex Pharmaceuticals, IQVIA, Alnylam Pharmaceuticals, Myriad Genetics, and Natera, with Myriad Genetics experiencing a notable drop following a fourth-quarter earnings report that missed revenue expectations.